Exicure, Inc. (XCUR)
NASDAQ·Healthcare·Biotechnology
$1.25
-3.10%
Mkt Cap $10.01M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$12.00
Range $12.00 – $12.00
Implied Upside
+860.0%
Consensus $12.00 vs current $1.25
NASDAQ·Healthcare·Biotechnology
$1.25
-3.10%
Mkt Cap $10.01M
No recent rating data.
Price Target (1 analysts)
$12.00
Range $12.00 – $12.00
+860.0%
Consensus $12.00 vs current $1.25